hims glp-1 news - Search News

Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 medications.

The Washington Post · 1d

Eli Lilly’s weight-loss drug no longer in shortage, FDA says

The announcement is a blow to the compounding pharmacies that have made cheaper, off-brand versions of the medication The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over,

The Wall Street Journal on MSN · 23h

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.

22hon MSN

For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away

Hims & Hers shares tanked after regulators signaled new limits on the production of versions of weight-loss drugs.

1don MSN

Hims & Hers Health Stock Is Tumbling Thursday: Here's Why

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Thursday after the U.S. Food and Drug Administration removed Eli ...

Hims & Hers: Shortage Saga Brings Stupendous Risk-Reward

Anticipating a 35% CAGR in 2025, Hims & Hers is poised for substantial growth. Read why I maintain my strong buy rating on ...

16d

Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform committed to breaking down ...

pharmaphorum5h

Mounjaro and Zepbound shortages over, declares FDA

The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli ...

Wall Street Breakfast Podcast: Spirit Airlines Exploring Bankruptcy Option - Report

Spirit Airlines considering bankruptcy filing - WSJ. Port strike ends as dockworkers said to agree on tentative deal with 62% ...

Today's Stocks on Sale: HIMS and More

Bearish investors decided to classify Hims & Hers Health (HIMS) as an obesity drug supplier. HIMS stock lost 9.6% on Thursday after the U.S. Food and Drug Administration said that GLP-1, made by Eli ...

15d

Hims & Hers offers compounded Wegovy for $99 a month to select professions

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Weight Loss Solutions for Front-Line Heroes: Hims & Hers Tackles Barriers

Hims & Hers is making GLP-1 weight loss medications more accessible with a 50% discount for front-line heroes. Mihir Gandhi ...

These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer

Market-beating returns could be on the way for patient investors in these two up-and-coming healthcare growth stocks.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics